Pharmafile Logo

TechnologyAdvice

- PMLiVE

Lilly’s ramucirumab boosts survival in lung cancer

Late-stage trial backs regulatory prospects

Novartis day

Novartis under fire in Japan over Diovan promotion

Offices raided amid investigation into falsified data

Lupin appoints European president

Maurice Chagnaud moves to India-based company from Teva

- PMLiVE

New operations head for Spirit Healthcare

Quentin Hayes joins from AstraZeneca

- PMLiVE

FDA mulls use of side effect voiceover in TV advertising

Agency considers updating how drug risks are communicated

- PMLiVE

This month in 1845: The birth of Robert Wood Johnson

A name that became part of a household brand

Strong sales increase for connected mobile health devices

Still a minority market in Europe but demand is rising

- PMLiVE

FDA approves Chelsea’s rare blood pressure drug

US biopharma company gets green light in US for Northera

- PMLiVE

NHS data project delayed in England

Public needs more time to learn about medical records database

- PMLiVE

A good reputation is more valuable than money

Putting patients at the heart of corporate culture is central to being a 'preferred partner'

Novartis building

Novartis skin cancer drug clears pivotal trial

Sonidegib achieves significant response in basal cell carcinoma patients

- PMLiVE

Actavis acquires Forest for $25bn

Ramps up its shift into speciality pharmaceuticals

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links